Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

Virology

Volumn 258, Issue 1, 1999, Pages 128-140

  Plotnicky Gilquin, Hélène ^a   Huss, Thierry ^a   Aubry, Jean Pierre ^a   Haeuw, Jean François ^a   Beck, Alain ^a   Bonnefoy, Jean Yves ^a   Nguyen, Thien Ngoc ^a   Power, Ultan F ^a  

^a Centre d'Immunologie Pierre Fabre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CYTOKINE PRODUCTION; EOSINOPHILIA; FEMALE; IMMUNIZATION; IMMUNOPATHOGENESIS; LUNG; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033602701     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9702     Document Type: Article

References (44)

1. Alwan W. H., Kozlowska W. J., Openshaw P. J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:1994;81-89.
2. Anderson L. J., Heilman C. A. Protective and disease-enhancing immune responses to respiratory syncytial virus. J. Infect. Dis. 171:1995;1-7.
3. Anderson L. J., Norden J., Saunders D., Toms G. L., Scott R. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J. Gen. Virol. 71:1990;1561-1570.
4. Anderson L. J., Tsou C., Potter C., Keyserling H. L., Smith T. F., Ananaba G., Bangham C. R. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 170:1994;1201-1208.
5. Barrera J. C., Letchworth G. J. Persistence of vesicular stomatitis virus New Jersey RNA in convalescent hamsters. Virology. 219:1996;453-464.
6. Brandt C., Power U. F., Plotnicky-Gilquin H., Huss T., Nguyen T., Lambert P-H., Binz H., Siegrist C-A. Protective immunity against respiratory syncytial virus in early life following murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. J. Infect. Dis. 176:1977;884-891.
7. Cane P. A., Mattews D. A., Pringle C. R. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J. Gen. Virol. 72:1991;2091-2096.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Collins P. L., McIntosh K., Chanock R. M. Respiratory syncytial virus. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1313-1351.
10. Connors M., Collins P. L., Firestone C. Y., Murphy B. R. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65:1991;1634-1637.
11. Connors M., Kulkarni A. B., Firestone C.-Y., Holmes K. L., Morse H. C. III, Sotnikov A. V., Murphy B. R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ cells. J. Virol. 66:1992;7444-7451.
12. Connors M., Giese N. A., Kulkarni A. B., Firestone C.-Y., Morse H. C., Murphy B. R. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:1994;5321-5325.
13. Corvaia N., Tournier P., Nguyen T. N., Haeuw J. F., Power U. F., Binz H., Andréoni C. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2Na, in aluminum hydroxide. J. Infect. Dis. 176:1997;560-569.
14. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., Garra A. O. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
15. Graham B. S., Henderson G. S., Tang Y.-W., Lu X., Neuzil K. M., Colley D. G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:1993;2032-2040.
16. Hancock G. E., Speelman D. J., Heers K., Bortell E., Smith J., Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70:1996;7783-7791.
17. Hegele R. G., Hayashi S., Bramley A. M., Hogg J. C. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest. 105:1994;1848-1854.
18. Hussell T., Spender L. C., Georgiou A., O Garra A., Openshaw P. J. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J. Gen. Virol. 77:1996;2447-2455.
19. Janezic A., Semper A., Holloway J., Holgate S. Detection of cytokine mRNA expression by a sensitive RT-PCR ELISA detection system. Biochemica. 3:1995;30-32.
20. Johnson P. R., Collins P. L. The A and B subgroups of human respiratory syncytial virus: Comparison of intergenic and gene-overlap sequences. J. Gen. Virol. 69:1988;2901-2906.
21. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:1969;422-434.
22. Libon C., Corvaia N., Haeuw J. F., Nguyen T. N., Ståhl S., Bonnefoy J.-Y., Andréoni C. The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein. Vaccine. 17:1999;406-414.
23. Makrides S. C., Nygren P. A., Andrews B., Ford P. J., Evans K. S., Hayman E. G., Adari H., Uhlen M., Toth C. A. Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor. J. Pharmacol. Exp. Ther. 277:1996;534-542.
24. Montgomery R. A., Dallman M. J. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J. Immunol. 147:1991;554-560.
25. Murby M., Samuelsson E., Nguyen T. N., Mignard L., Power U., Binz H., Uhlen M., Stahl S. Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus. Eur. J. Biochem. 230:1995;38-44.
26. Murphy B. R., Hall S. L., Kulkarni A. B., Crowe J. E. Jr., Collins P. L., Connors M., Karron R. A., Chanock R. M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:1994;13-36.
27. Murphy B. R., Sotnikov A., Lawrence L. A., Banks S. M., Prince G. A. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine. 8:1990;497-502.
28. Nguyen T. N., Uhlén M., Ståhl S. De novo gene assembly using a paramagnetic solid support. Uhlén M., Hornes E., Olsvik O. Advances in Biomagnetic Separation. 1994;73-78 Eaton, Natick.
29. Nygren, P. À. Flodby, P. Andersson, R. Wigzell, H. Uhlen, M. 1991, In vivo stabilization of a human recombinant CD4 derivative by fusion to a serum albumin-binding receptor, In, Vaccines 91, Modern Approaches to Vaccine Development, R. M. ChanockF. BrownH. S. GinsbergR. A. Lerner, 363, 368, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Openshaw P. J. M. Pulmonary epithelial T cells induced by viral infection express T cell receptors alpha/beta. Eur. J. Immunol. 21:1991;803-806.
31. d. J. Virol. 64:1990;1683-1689.
32. Power U. F., Plotnicky-Gilquin H., Huss T., Robert A., Trudel M., Stahl S., Uhlen M., Nguyen T. N., Binz H. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology. 230:1997;155-166.
33. Prince G. A., Jenson A. B., Hemming V. G., Murphy B. R., Walsh E. E., Horswood R. L., Chanock R. M. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:1986;721-728.
34. Routledge E. G., Willcocks M. M., Samson A. C., Morgan L., Scott R., Anderson J. J., Toms G. L. The purification of four respiratory syncytial virus proteins as protective agents against experimental infection in BALB/c mice. J. Gen. Virol. 69:1988;293-303.
35. Sparer T. E., Matthews S., Hussel T., Rae A. J., Garcia-Barreno B., Melero J. A., Openshaw P. J. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187:1998;1921-1926.
36. Stott E. J., Taylor G., Ball L. A., Anderson K., Young K. K., King A. M., Wertz G. W. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J. Virol. 61:1987;3855-3861.
37. Swain S. L. Lymphokines and the immune response: The central role of interleukin-2. Curr. Opin. Immunol. 3:1991;304-310.
38. Taylor G., Stott E. J., Hayle A. J. Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J. Gen. Virol. 66:1985;2533-2538.
39. Tebbey P. W., Hagen M., Hancock G. E. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 10:1998;1967-1972.
40. Trudel M., Nadon F., Seguin C., Binz H. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein. Virology. 185:1991;749-757.
41. Vaux-Peretz F., Chapsal J. M., Meignier B. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice. Vaccine. 10:1992;113-118.
42. Waris M. E., Tsou C., Erdman D. D., Day D. B., Anderson L. J. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge of BALB/c mice immunized with formalin-inactivated RSV. J. Virol. 71:1997;6935-6939.
43. Waris M. E., Tsou C., Erdman D. D., Zaki S. R., Anderson L. J. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:1996;2852-2860.
44. Wertz G. W., Collins P. L., Huang Y., Gruker C., Levine S., Ball L. A. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc. Natl. Acad. Sci. USA. 82:1985;4075-4079.